FibroBiologics, Inc. (FBLG)
1.32
+0.01
(+0.76%)
USD |
NASDAQ |
Apr 30, 12:56
FibroBiologics EPS Diluted (Quarterly) : -0.9754 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Fate Therapeutics, Inc. | -0.2715 |
| Longeveron, Inc. | -0.2374 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Agenus, Inc. | -0.301 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.244M |
| Total Expenses (Quarterly) | 3.244M |
| Enterprise Value | 2.118M |
| Earnings Yield | -470.1% |
| Normalized Earnings Yield | -452.79 |